Skip to main content
. 2020 Oct 29;12(11):1038. doi: 10.3390/pharmaceutics12111038

Figure 5.

Figure 5

Myeloperoxidase (A) and alkaline phosphatase (B) activity after treatment of experimental colitis (90 mg/kg TNBS) with chitosans of different DD (70% and 95%) and viscosities (10 and 3000 mPas) at a dose of 30 mg/kg in combination with 5-ASA at a dose of 30 mg/kg, (−): healthy control, (+): untreated colitis control (mean ± SD; n = 5; * p < 0.05, Dunnett’s test.).